Centene Corporation (CNC)
NYSE: CNC · Real-Time Price · USD
66.68
+0.91 (1.38%)
Aug 10, 2026, 11:59 AM EDT - Market open
Centene Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 202,938 | 194,777 | 163,071 | 153,999 | 144,547 | 125,982 |
Revenue Growth | 13.89% | 19.44% | 5.89% | 6.54% | 14.74% | 13.38% |
Gross Profit Gross Profit Growth | 40,453 | 34,405 | 34,635 | 31,541 | 25,986 | 22,486 |
Operating Income Operating Income Growth | -5,640 | -7,623 | 3,175 | 2,930 | 1,318 | 1,784 |
Net Income Net Income Growth | -5,100 | -6,674 | 3,305 | 2,702 | 1,202 | 1,347 |
Earnings Per Share EPS Growth | -10.44 | -13.53 | 6.31 | 4.95 | 2.07 | 2.28 |
EPS Growth | - | - | 27.47% | 139.13% | -9.21% | -26.92% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Medicaid Medicaid Growth | 116,861 | 110,434 | 101,417 | 100,759 | 93,151 | 84,139 |
Medicare Medicare Growth | 40,384 | 37,210 | 23,032 | 22,261 | 22,484 | 17,512 |
Commercial Commercial Growth | 40,696 | 42,003 | 33,702 | 24,845 | 17,380 | 16,956 |
Other Other Growth | 4,997 | 5,130 | 4,920 | 6,134 | 11,532 | 7,375 |
Revenue (Total) Revenue (Total) Growth | 202,938 | 194,777 | 163,071 | 153,999 | 144,547 | 125,982 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 27,057 | 20,320 | 16,685 | 19,652 | 14,395 | 14,657 |
Total Debt Total Debt Growth | 16,105 | 17,401 | 18,533 | 17,829 | 18,020 | 18,838 |
Net Cash (Debt) Net Cash Growth | 10,952 | 2,919 | -1,848 | 1,823 | -3,625 | -4,181 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 22.17 | 5.92 | -3.53 | 3.34 | -6.23 | -7.08 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 9,749 | 5,088 | 154 | 8,053 | 6,261 | 4,205 |
Capital Expenditures CapEx Growth | -798 | -767 | -644 | -799 | -1,004 | -910 |
Free Cash Flow Free Cash Flow Growth | 8,951 | 4,321 | -490 | 7,254 | 5,257 | 3,295 |
Free Cash Flow Growth | 728.80% | - | - | 37.99% | 59.55% | -28.89% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 19.93% | 17.66% | 21.24% | 20.48% | 17.98% | 17.85% |
Operating Margin | -2.78% | -3.91% | 1.95% | 1.90% | 0.91% | 1.42% |
Pretax Margin | -2.28% | -3.45% | 2.61% | 2.34% | 1.36% | 1.44% |
Profit Margin | -2.52% | -3.43% | 2.02% | 1.75% | 0.83% | 1.06% |
FCF Margin | 4.41% | 2.22% | -0.30% | 4.71% | 3.64% | 2.62% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 9.60 | 14.99 | 39.62 | 36.14 |
Forward PE | 14.23 | 17.68 | 8.90 | 11.71 | 13.56 | 15.17 |
P/FCF Ratio | 3.69 | 4.68 | - | 5.47 | 8.59 | 14.57 |
PS Ratio | 0.18 | 0.10 | 0.18 | 0.26 | 0.31 | 0.38 |